Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 May 2023 | Story Leonie Bolleurs | Photo Supplied
Eco-vehicle Race
Join the UFS on 13 May 2023 at 09:00 (student performances at 09:00 and race at 10:15) on the road around the UFS Odeion School of Music for the annual Kovsie ACT Eco-Vehicle Race. Don't miss out on this incredible display of endurance; support your favourite team to victory!

Kovsie ACT at the University of the Free State (UFS) is presenting the sixth Kovsie Eco-Vehicle Race this year.

Come and show your support for our students who will be representing our colleges and three campuses, along with the Central University of Technology. Be a part of the action:

Date: Saturday 13 May 2023
Time: 09:00 Performances by student artists
Time: 10:15 Official start of Eco-Vehicle Race
Venue: UFS Odeion School of Music parking area

The Eco-Vehicle Race represents the last phase of a nine-month co-curricular skills programme, providing our students with a set of skills that prepare them for the world of work. 

In this programme where students are equipped with basic knowledge and skills on sustainable energy, they get the opportunity not only to race the eco-vehicles, but to also understand the workings of the vehicle, which is critical for repairs done by the team during the race. 

Our students will be competing in three events:

  • Obstacle course: Teams will be challenged by obstacles to test their control over the car.
  • Smart lap: A timed lap in which the drivers take the main track for the first time.
  • Endurance race: The teams need to finish as many laps as possible using the least amount of energy in 45 minutes. 
The winners of the three events will each receive a trophy. There will be a trophy for the best pit stop as well as a spirit cup for the team with the best energy and support from the audience.

Come and support our students as they showcase their ingenuity and endurance. Don't miss out on the action! For more information, click here to contact Jady Carelse.

Car manufacturers will also exhibit hybrid/electric vehicles; come and view the exhibition and learn more about how these cars work and their benefits.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept